Drugs Made In America Acquisition Corp
DMAAU10.400USD
-0.180-1.70%
Horarios del mercado （ET）Cotizaciones retrasadas 15 min
0.00Cap. mercado
--P/E TTM
Más Datos de Drugs Made In America Acquisition Corp Compañía
Drugs Made In America Acquisition Corp. is a blank check company. The Company is incorporated as an exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. Its efforts to identify a prospective target business will not be limited to a particular industry or geographic region although it intends to focus its search for business combination targets in the pharmaceutical industry.
Información de la empresa
Símbolo de cotizaciónDMAAU
Nombre de la empresaDrugs Made In America Acquisition Corp
Fecha de salida a bolsaJan 28, 2025
Director ejecutivoMs. Lynn Stockwell
Número de empleados- -
Tipo de seguridadUnit
Fin del año fiscal- -
Dirección1 East Broward Boulevard
CiudadFT LAUDERDALE
Bolsa de valoresNASDAQ Global Market Consolidated
PaísUnited States of America
Código postal33301
Teléfono19548703099
Sitio Web
Símbolo de cotizaciónDMAAU
Fecha de salida a bolsaJan 28, 2025
Director ejecutivoMs. Lynn Stockwell
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Myron W. Shulgan
Mr. Myron W. Shulgan
Independent Director Nominee
Independent Director Nominee
--
--
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Mr. Glenn C. Worman
Mr. Glenn C. Worman
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Catherine Do
Dr. Catherine Do
Independent Director Nominee
Independent Director Nominee
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Myron W. Shulgan
Mr. Myron W. Shulgan
Independent Director Nominee
Independent Director Nominee
--
--
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Mr. Glenn C. Worman
Mr. Glenn C. Worman
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Catherine Do
Dr. Catherine Do
Independent Director Nominee
Independent Director Nominee
--
--
Desglose de ingresos
Sin datos
Sin datos
Por negocio
Por región
Sin datos
Estadísticas de accionistas
Actualizado: sáb., 17 de may
Actualizado: sáb., 17 de may
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Drugs Made In America Acquisition LLC
17.88%
Heights Capital Management, Inc.
2.77%
Boothbay Fund Management, LLC
2.58%
Westchester Capital Management, LLC
2.13%
RiverNorth Capital Management LLC
1.79%
Other
72.84%
Accionistas
Accionistas
Proporción
Drugs Made In America Acquisition LLC
17.88%
Heights Capital Management, Inc.
2.77%
Boothbay Fund Management, LLC
2.58%
Westchester Capital Management, LLC
2.13%
RiverNorth Capital Management LLC
1.79%
Other
72.84%
Tipos de accionistas
Accionistas
Proporción
Corporation
17.88%
Investment Advisor/Hedge Fund
7.68%
Hedge Fund
3.54%
Investment Advisor
2.85%
Research Firm
0.03%
Other
68.02%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
20
7.49M
31.98%
+7.31M
2025Q1
20
7.60M
32.43%
+7.41M
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Drugs Made In America Acquisition LLC
4.19M
17.88%
+4.19M
--
Feb 18, 2025
Heights Capital Management, Inc.
650.00K
2.77%
+650.00K
--
Mar 31, 2025
Boothbay Fund Management, LLC
603.75K
2.58%
+603.75K
--
Mar 31, 2025
Westchester Capital Management, LLC
500.00K
2.13%
+500.00K
--
Mar 31, 2025
RiverNorth Capital Management LLC
420.50K
1.79%
+418.00K
+16719.92%
Mar 31, 2025
Context Capital Management LLC
250.00K
1.07%
+250.00K
--
Mar 31, 2025
Schonfeld Strategic Advisors LLC
234.83K
1%
+234.83K
--
Mar 31, 2025
Bulldog Investors, LLP
130.26K
0.56%
+130.26K
--
Mar 31, 2025
Wolverine Asset Management, LLC
130.00K
0.55%
+130.00K
--
Mar 31, 2025
Verition Fund Management LLC
100.00K
0.43%
+100.00K
--
Mar 31, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 2 de ago
Actualizado: sáb., 2 de ago
Nombre
Proporción
SPAC and New Issue ETF
2.39%
RiverNorth Enhanced Pre-Merger SPAC ETF
0.51%
CrossingBridge Pre-Merger SPAC ETF
0%
SPAC and New Issue ETF
Proporción2.39%
RiverNorth Enhanced Pre-Merger SPAC ETF
Proporción0.51%
CrossingBridge Pre-Merger SPAC ETF
Proporción0%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
